116 related articles for article (PubMed ID: 2472784)
1. Detection of metastatic breast carcinoma with monoclonal antibodies to cytokeratins.
Sedmak DD; Meineke TA; Knechtges DS
Arch Pathol Lab Med; 1989 Jul; 113(7):786-9. PubMed ID: 2472784
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of cytokeratin-positive breast cancer metastases.
Sedmak DD; Meineke TA; Knechtges DS; Anderson J
Mod Pathol; 1989 Sep; 2(5):516-20. PubMed ID: 2479008
[TBL] [Abstract][Full Text] [Related]
3. Infiltrating lobular breast carcinoma: detection of occult regional lymph node metastasis by immunohistochemistry.
Kainz C; Gitsch G; Lee A; Danihel L; Breitenecker G
Anticancer Res; 1993; 13(1):73-4. PubMed ID: 7682802
[TBL] [Abstract][Full Text] [Related]
4. [Detection of metastases in breast cancer. Comparative histologic and immunohistochemical studies with monoclonal anti-cytokeratin antibodies of the axillary lymph nodes].
Stosiek P; Kasper M; Goertchen R; Karsten U
Pathologe; 1986 Nov; 7(6):324-6. PubMed ID: 2433684
[No Abstract] [Full Text] [Related]
5. Detection of occult metastatic lobular carcinoma in axillary lymph nodes using anticytokeratin monoclonal antibodies.
Lachman MF; Ricci A; Pedersen CA; Cartun RW; Strumpf KB
Conn Med; 1992 Feb; 56(2):65-8. PubMed ID: 1373112
[TBL] [Abstract][Full Text] [Related]
6. [Intraoperative evaluation of axillary lymph nodes for micrometastases using immunohistochemistry--preliminary study].
Sawada T; Sakurada M; Hasegawa Y; Kobayashi M
Rinsho Byori; 2003 Jun; 51(6):522-7. PubMed ID: 12884738
[TBL] [Abstract][Full Text] [Related]
7. [Detection of micrometastases in axillary lymph nodes of node-negative breast cancer patients and its clinical significance].
Wu J; Yu Z; Li G
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):289-91. PubMed ID: 9387324
[TBL] [Abstract][Full Text] [Related]
8. [Detection of lymph nodes micrometastases in breast carcinoma using immunohistochemistry for cytokeratin 8].
Cianga C; Cianga P; Cozma L; Diaconu C; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2002; 106(4):720-4. PubMed ID: 14974217
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
10. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
Reed W; Bøhler PJ; Sandstad B; Nesland JM
Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody cocktail for detection of micrometastatic tumor cells in the bone marrow of breast cancer patients.
Taha M; Ordoñez NG; Kulkarni S; Owen M; Ro JS; Hortobagyi G; Reading CL; Dicke KA; Spitzer G
Bone Marrow Transplant; 1989 May; 4(3):297-303. PubMed ID: 2471564
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
13. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
[TBL] [Abstract][Full Text] [Related]
14. The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastases.
Byrne J; Waldron R; McAvinchey D; Dervan P
Eur J Surg Oncol; 1987 Oct; 13(5):409-11. PubMed ID: 3311817
[TBL] [Abstract][Full Text] [Related]
15. Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice.
Fréneaux P; Nos C; Vincent-Salomon A; Genin P; Sigal-Zafrani B; Al Ghuzlan A; Birolini MJ; Clough K; Sastre-Garau X
Mod Pathol; 2002 Jun; 15(6):641-6. PubMed ID: 12065778
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.
Salem AA; Douglas-Jones AG; Sweetland HM; Mansel RE
Eur J Surg Oncol; 2006 Jun; 32(5):484-7. PubMed ID: 16569493
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of lymph node metastases in node-negative breast cancer patients.
Kohlberger P; Gantert M; Volk-Orlowska T; Kieback DG; Gitsch G
Anticancer Res; 2001; 21(1B):697-9. PubMed ID: 11299828
[TBL] [Abstract][Full Text] [Related]
18. Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11.
Galea MH; Athanassiou E; Bell J; Dilks B; Robertson JF; Elston CW; Blamey RW; Ellis IO
J Pathol; 1991 Nov; 165(3):221-7. PubMed ID: 1722247
[TBL] [Abstract][Full Text] [Related]
19. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ.
El-Tamer M; Chun J; Gill M; Bassi D; Lee S; Hibshoosh H; Mansukhani M
Ann Surg Oncol; 2005 Mar; 12(3):254-9. PubMed ID: 15827818
[TBL] [Abstract][Full Text] [Related]
20. Presence of breast cancer antigens in uninvolved axillary lymph nodes.
Hendler FJ; House D
Cancer Res; 1985 Jul; 45(7):3364-73. PubMed ID: 4005859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
